Age-dependent Efficacy and Safety of Nivolumab (NIVO) as Monotherapy or Combination Therapy with Ipilimumab (NIVO plus IPI) in Patients with advanced Melanoma in the non-interventional Study (NIS) NICO

Schadendorf, D. and Ugurel, S. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Gebhardt, C. and Göppner, D. and Haferkamp, Sebastian and Herbst, R. and Kähler, K. and Kreuter, A. and Meier, F. and Pföhler, C. and Sachse, M. M. and Sickmann, T. and Terheyden, P. and Ulrich, J. and Utikal, J. S. and Grimmelmann, I. and Gutzmer, R. (2021) Age-dependent Efficacy and Safety of Nivolumab (NIVO) as Monotherapy or Combination Therapy with Ipilimumab (NIVO plus IPI) in Patients with advanced Melanoma in the non-interventional Study (NIS) NICO. In: 31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, hybrid.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Speech)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Petra Gürster
Date Deposited: 13 Dec 2022 07:04
Last Modified: 13 Dec 2022 07:10
URI: https://pred.uni-regensburg.de/id/eprint/47868

Actions (login required)

View Item View Item